<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02824367</url>
  </required_header>
  <id_info>
    <org_study_id>PI2014_843_0002</org_study_id>
    <secondary_id>2013-A01302-43</secondary_id>
    <nct_id>NCT02824367</nct_id>
  </id_info>
  <brief_title>Evaluation of Clinical Perfectionism in Parkinson Disease</brief_title>
  <acronym>EPMP-1</acronym>
  <official_title>Evaluation of Clinical Perfectionism in Parkinson Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer&#xD;
      of depression and / or anxiety.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer&#xD;
      of depression and / or anxiety. Also, clinicians reported that they exhibit specific&#xD;
      personality traits (e.g., rigidity and perfectionism).&#xD;
&#xD;
      To date, few studies used Cognitive Behavioural Therapies (CBT) in people with Parkinson's&#xD;
      disease showing promising results. Recently, perfectionism has received particular attention&#xD;
      because of it association with many emotional disorders. Thus, some psychometric tools have&#xD;
      been developed in order to evaluate different aspects of perfectionism. Yet, none of them has&#xD;
      been used in people with Parkinson's disease.&#xD;
&#xD;
      The objective of this study is to investigate whether there is a direct link between&#xD;
      Parkinson's disease and perfectionism by using psychometric tools from the CBT literature.&#xD;
      Identifying such link would allow to justify the use of CBT in people with Parkinson's&#xD;
      disease with the goal in mind to improve their care and quality of life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">October 6, 2014</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perfectionism evaluation 1</measure>
    <time_frame>Day 0</time_frame>
    <description>Scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Perfectionism evaluation 2</measure>
    <time_frame>Day 0</time_frame>
    <description>Hewitt Multidimensional Perfectionism Scale (HMPS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression and anxiety evaluation 1</measure>
    <time_frame>Day 0</time_frame>
    <description>Scores to depression scale (Beck Depression Inventory (BDI))</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression and anxiety evaluation 2</measure>
    <time_frame>Day 0</time_frame>
    <description>anxiety scale (State Trait Anxiety Inventory (STAI))</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Parkinsonian</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient Arm: Parkinsonian will complete several scale of evaluation. Behavioral: Completion of scales evaluation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dystonic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Comparator Arm: Dystonic patient will complete several scale of evaluation. Behavioral: Completion of scales evaluation</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Completion of scales evaluation</intervention_name>
    <description>Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))</description>
    <arm_group_label>Dystonic</arm_group_label>
    <arm_group_label>Parkinsonian</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age greater than 18 years&#xD;
&#xD;
          -  Score Mini Mental Scale (MMS) greater than 23&#xD;
&#xD;
          -  For Parkinsonian, Parkinson disease be defined according to the criteria of the&#xD;
             Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3&#xD;
&#xD;
          -  The control patients present dystonias not within the scope of Parkinson&#xD;
&#xD;
          -  Informed Consent Form signed&#xD;
&#xD;
          -  Patient covered by social insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Proven Presence of neuropsychological disorders&#xD;
&#xD;
          -  Patients with deep brain stimulation&#xD;
&#xD;
          -  Diagnosis of somatic pathology diagnosed&#xD;
&#xD;
          -  Private Patient freedom or protected adult (under guardianship)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre KRYSTKOWIAK, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>April 22, 2014</study_first_submitted>
  <study_first_submitted_qc>July 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2016</study_first_posted>
  <last_update_submitted>August 20, 2018</last_update_submitted>
  <last_update_submitted_qc>August 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson</keyword>
  <keyword>Perfectionism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

